Resources
for Patients
& Families

Resources for
Researchers

Find out about upcoming NEALS meetings, learn more about our trial resources, and stay in touch with the latest ALS research findings.

Researcher Resources >>

The mission of Northeast ALS Consortium (NEALS) is to rapidly translate scientific advances into
clinical research and new treatments for people with Amyotrophic Lateral Sclerosis (ALS)
and motor neuron disease.


	Resources for Patients & Families
	Selection Trial in ALS Webinar Posted
	If you missed Dr. Nazem Atassi's presentation of the Selection Trial of High Dosage Creatine and Two Dosage of Tamoxifen, it has been archived. You can view it here>>
	May Clinical Trial E-Update
	What is coming down the ALS research pipeline? In this issue: NEALS trials enrolling soon, Neuralstem phase II trial approved, and ALS awareness month. Find out more>> Watch the Spring 2013 Clinical Trial Pipeline Webinar Archive If you missed Dr. Merit Cudkowicz's research update webinar, or would like to see it again, it is now posted and available for viewing. Watch it here>>


	Resources for Researchers
	Request for Proposals
	The MGH Neurological Clinical Research Institute (NCRI) and The ALS Association are pleased to announce a call for phase II clinical trial applications for novel, high-potential treatments in ALS. A letter of intent is due May 20th. Get more information>>
	PRO-ACT Platform gets Bio IT World Award
	Mass General NCRI and Prize4Life receive Best Practice Award for PRO-ACT, a powerful tool that merges data from existing publicly and privately conducted ALS clinical trials. Read the Press Release>> NEALS Samples Samples from the NEALS repository are available to researchers for the purpose of furthering the understanding of ALS or motor neuron disease and developing disease biomarkers. Get the samples>>

News & Events


	Dr. Merit Cudkowicz Answers Your Clinical Trial Questions
	NEALS Co-Chair Dr. Cudkowicz was featured in an MDA article on the state of ALS clinical trials. Read the Q&A here>>
	US Brainstorm Trial Statement We have had many inquires regarding the Brainstorm Stem Cell Therapeutics Clinical Trial. Read the US Brainstorm Trial Statement>>
	Philadelphia Clinical Research Learning Institute An intensive program dedicated to educating attendees on clinical research and therapy development and empowering this group to be advocates for ALS clinical research. Learn more about attending>> Cytokinetics Announces Opening of BENEFIT-ALS A Phase IIb Clinical Trial of Tirasemtiv (CK-2017357) As sites become activated for this Phase IIB BENEFIT-ALS trial, they will be added to the NEALS trial database. Find research sites>> MORE NEWS

Our Generous Sponsors


For Patients & Families Educational Webinars Online NEALS Resources Other Resources Contact a Disease Specialist Clinical Research Blog For Researchers Become a NEALS member Post an ALS Clinical Trial NEALS CRO Capabilities Annual NEALS Meeting NEALS Samples NEALS Historical Data	ALS Trials Browse Recruiting Trials Search for a Trial Clinical Trial News Clinical Trials 101 Get Involved Donate samples Donate to our Clinical Research	About Us Our Mission Our Structure Our Research NEALS Members Motor Neuron Disease